Number of Cancer Survivors Set to Top 22 Million by 2030
TUESDAY, June 11, 2019 -- The number of cancer survivors is projected to increase to more than 22.1 million by Jan. 1, 2030, based on growth and aging of the population alone, according to a study published online June 11 in CA: A Cancer Journal for Clinicians.
Kimberly D. Miller, M.P.H., from the American Cancer Society in Atlanta, and colleagues estimated cancer prevalence using incidence and survival data, vital statistics, and population projections. They presented current treatment patterns for the most prevalent cancer types.
The researchers found that on Jan. 1, 2019, more than 16.9 million Americans (8.1 million men and 8.8 million women) with a history of cancer were alive. Based on the growth and aging of the population alone, this number is projected to increase to more than 22.1 million by Jan. 1, 2030. In 2019, the most prevalent cancers were prostate, colon and rectum, and melanoma of the skin among men and breast, uterine corpus, and colon and rectum among women. Fifty-six percent of survivors were diagnosed in the past 10 years, and 64 percent are aged ≥65 years.
"Models for the integration of comprehensive care for cancer survivors and their caregivers, including self-management, wellness and healthy lifestyle promotion, and cancer rehabilitation, are beginning to emerge," the authors write. "As the evidence base grows, efforts at the individual, provider, system, and policy levels will help cancer survivors live longer and healthier lives."
© 2020 HealthDay. All rights reserved.
Posted: June 2019
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.